埃博拉病毒感染性标本在生物安全三级实验室的临床检验与生物安全防护  

Clinical examination and personal biosafety protection for infectious specimens with Ebola virus in biosafety level 3 laboratory

作　　者：郑江花[1] 胡绿荫[1] 李海聪[1] 王刚[1] 毛会军[1] 曹宇硕 卢洪洲[1,2] 

机构地区：[1]上海市(复旦大学附属)公共卫生临床中心,201508 [2]复旦大学附属华山医院感染病科,上海200040

出　　处：《传染病信息》2014年第5期257-259,261,共4页Infectious Disease Information

基　　金：国家863项目(SS2014AA021403);上海市公共卫生临床中心科研启动基金(201301;201309)

摘　　要：本文参考美国疾病预防控制中心的最新资讯和中国疾病预防控制中心制定的《埃博拉出血热个人防护指南(第二版)》,介绍当前在生物安全三级实验室开展埃博拉病毒感染者血液标本临床检验策略的最新研究进展,主要包括临床检验的操作流程以及操作人员必要的生物安全防护要点。In compliance with the latest informations released by American Centers for Disease Control and Prevention（CDC）and the＂Ebola hemorrhagic fever personal protection guide（second edition）,＂issued by China Center for Disease Control and Prevention, we present and describe here the latest research progresses about performing clinical examinations strategies for infectious blood samples with Ebola virus from patients in biosafety level 3 laboratory at present. The presenting main contents at present include standard operating procedures for clinical examinations and key points about personal biosafety protection when laboratory technicians operate in biosafety level 3 laboratory.

关 键 词：埃博拉病毒属 临床试验 检疫 

分 类 号：R373.32[医药卫生—病原生物学]